Am J Epidemiol. 2021 Oct 1;190(10):2085-2093. doi: 10.1093/aje/kwab145.
Administration of many childhood vaccines requires that multiple doses be delivered within a narrow time window to provide adequate protection and reduce disease transmission. Accurately quantifying vaccination coverage is complicated by limited individual-level data and multiple vaccination mechanisms (routine and supplementary vaccination programs). We analyzed 12,541 vaccination cards from 6 districts across Madagascar for children born in 2015 and 2016. For 3 vaccines-pentavalent diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine (DTP-HB-Hib; 3 doses), 10-valent pneumococcal conjugate vaccine (PCV10; 3 doses), and rotavirus vaccine (2 doses)-we used dates of vaccination and birth to estimate coverage at 1 year of age and timeliness of delivery. Vaccination coverage at age 1 year for the first dose was consistently high, with decreases for subsequent doses (DTP-HB-Hib: 91%, 81%, and 72%; PCV10: 82%, 74%, and 64%; rotavirus: 73% and 63%). Coverage levels between urban districts and their rural counterparts did not differ consistently. For each dose of DTP-HB-Hib, the overall percentage of individuals receiving late doses was 29%, 7%, and 6%, respectively; estimates were similar for other vaccines. Supplementary vaccination weeks, held to help children who had missed routine care to catch up, did not appear to increase the likelihood of being vaccinated. Maintaining population-level immunity with multiple-dose vaccines requires a robust stand-alone routine immunization program.
为了提供充分的保护并减少疾病传播,许多儿童疫苗的接种需要在狭窄的时间窗口内多次接种。由于个体层面数据有限和多种接种机制(常规和补充接种计划),准确量化疫苗接种覆盖率变得复杂。我们分析了马达加斯加六个地区的 12541 张 2015 年和 2016 年出生儿童的接种卡。对于三种疫苗——五联疫苗(白喉、破伤风、百日咳、乙型肝炎和流感嗜血杆菌疫苗;3 剂)、10 价肺炎球菌结合疫苗(PCV10;3 剂)和轮状病毒疫苗(2 剂)——我们使用接种日期和出生日期来估计 1 岁时的接种覆盖率和接种及时性。首剂接种的 1 岁时接种覆盖率始终很高,随后剂量的接种覆盖率逐渐下降(五联疫苗:91%、81%和 72%;PCV10:82%、74%和 64%;轮状病毒:73%和 63%)。城市地区和农村地区之间的接种水平没有一致的差异。对于每剂五联疫苗,接受迟种剂量的个体总体百分比分别为 29%、7%和 6%;其他疫苗的估计值也相似。为了帮助错过常规护理的儿童赶上进度而举行的补充接种周似乎并没有增加接种的可能性。维持多剂疫苗的人群免疫水平需要一个强大的独立常规免疫规划。